Percanib 80 mg (Selpercatinib) Capsules
Introduction: Percanib 80 mg, enriched with Selpercatinib and produced by Drug International Ltd., marks a transformative advancement in the realm of precision oncology. This innovative treatment brings targeted therapy to patients with specific genetic mutations, heralding a new era of hope and enhanced treatment outcomes for those facing advanced cancer stages. Description and Usage: Percanib […]
Rutinib Cream (Ruxolitinib 1.5%)
Introduction: Rutinib Cream, featuring Ruxolitinib Phosphate INN and developed by Drug International Ltd., marks a significant milestone in dermatological treatments. Supplied worldwide by Onco Solution, this innovative cream offers specialized relief for various inflammatory skin conditions, setting new standards for effective symptom management and skin restoration. Rutinib Cream: Targeting Inflammatory Skin Conditions: Rutinib harnesses the […]
Acalanib 100 MG (Acalabrutinib) Capsules
Introduction: In the ever-evolving landscape of oncology, Acalanib 100 mg, meticulously manufactured by Drug International Ltd., emerges as a beacon of hope and a harbinger of precision medicine. Teaming up with Supplier Onco Solution, a global powerhouse in medicine supply and information provision, this medication signifies a quantum leap in the pursuit of effective and […]
Pronex 40 MG (Esomeprazole) Capsules
Introduction of Pronex 40 mg: In the realm of gastrointestinal health, Pronex 40 , featuring the potent active ingredient Esomeprazole, emerges as a steadfast solution crafted by Drug International Ltd. Distributed globally by Onco Solution, Pronex 40 mg transcends conventional boundaries to offer comprehensive support for gastric well-being. This narrative endeavors to dissect the multifaceted […]
Anib 40 MG (Afatinib) Tablets
Introduction of Anib 40 MG In the dynamic landscape of oncology, the unveiling of Anib 40 by Drug International Ltd. marks a significant milestone. This groundbreaking medication, featuring the potent Afatinib, promises a paradigm shift in cancer treatment. Collaborating with Onco Solution, a global leader in oncology-based solutions, Anib 40 emerges as a beacon of […]
Getinib 250 MG (Gefitinib) Tablets
Introduction: In the dynamic realm of oncology, Drug International Ltd. proudly introduces Getinib 250 , a revolutionary formulation featuring the potent Gefitinib. In close collaboration with Onco Solution, a globally esteemed leader in oncology medicine supply and information dissemination, Getinib 250 stands at the forefront of cutting-edge cancer therapies. This narrative endeavors to delve deeper […]
Veneta 100 MG (Venatadax) Tablets
Introduction to Veneta 100 MG (Venatadax) Tablets: In the dynamic arena of oncology, the collaboration between Drug International Ltd. and Onco Solution has birthed Veneta 100 , an avant-garde formulation featuring the groundbreaking compound Venatadax. This revolutionary medication not only symbolizes a new frontier in cancer treatment but also embodies the synergistic efforts of a […]
Mylomid 25 MG (Lenalidomide) Capsules
Introduction Mylomid 25 mg: In the relentless battle against cancer, Mylomid 25 emerges as a beacon of hope and progress. Developed through the collaborative efforts of Drug International Ltd. and Onco Solution, this medication represents a significant milestone in oncology care. With its active ingredient Lenalidomide, Mylomid 25 embodies a commitment to excellence, innovation, and […]
M-Son Spray (Mometasone Furoate)
Introduction: In the dynamic realm of oncology, where precision and efficacy stand as paramount pillars, the collaboration between Drug International Ltd. and Supplier Onco Solution unfolds a new chapter with the introduction of M-Son Spray. This innovative medication, featuring Mometasone Furoate, not only signifies a breakthrough in cancer care but also exemplifies the commitment to […]
Hertinib 40 MG (Neratinib) Tablets
Introduction: In the ever-evolving realm of oncology, where the fusion of innovation and compassion is paramount, Drug International Ltd. and Supplier Onco Solution collaborate to introduce Hertinib 40 , a groundbreaking medication featuring Neratinib. This alliance signifies a transformative shift in cancer care, uniting Drug International Ltd.’s expertise in pharmaceutical excellence with Supplier Onco Solution’s […]
Febox 80 MG (Febuxostat) Tablets
Introduction of Febox 80 MG: In the dynamic landscape of oncology, Drug International Ltd. proudly presents Febox 80, a testament to cutting-edge pharmaceutical innovation. This collaborative venture with Supplier Onco Solution amplifies global accessibility and information dissemination, marking a paradigm shift in cancer care. Febox 80, enriched with Febuxostat, extends beyond traditional treatments, embodying a […]
Lotenib 100 mg (Larotrectinib) Capsules
Introduction: In the dynamic realm of oncology, Lotenib 100 mg, meticulously crafted by the pharmaceutical prowess of Drug International Ltd., emerges as a revolutionary force in the landscape of oncological therapeutics. In partnership with Supplier Onco Solution, this groundbreaking medication delivers a potent treatment option and serves as a conduit of invaluable information on various […]
Renib 40 mg (Regorafenib) Tablets
Introduction: In the relentless battle against cancer, Renib 40 mg emerges as a beacon of hope, offering patients a potent weapon against the complexities of malignancies. Manufactured with precision by Drug International Ltd. and globally distributed by Supplier Onco Solution, this medication signifies a significant advancement in oncology therapeutics. This narrative aims to unravel the […]
Palbo 125 MG (Palbociclib) Capsules
Palbo 125 MG Capsule: Revolutionizing Targeted Cancer Therapy Palbo 125 mg Capsule stands at the forefront of revolutionary advancements in targeted cancer therapy. Developed with meticulous precision by Drug International Ltd., this medication encapsulates Palbociclib, a potent inhibitor of cyclin-dependent kinase (CDK) 4/6 pathways. In this comprehensive guide, we delve into the intricate details of […]
Lorlanib 100 mg (Lorlatinib) Tablets
Introduction: In the ever-evolving landscape of oncology, Drug International Ltd. proudly presents Lorlanib 100 mg, featuring Lorlatinib INN, a groundbreaking medication that stands as a vanguard in the relentless pursuit of precision in cancer treatment. Facilitated by Onco Solution, a global leader in medicine supply and oncology information, Lorlanib 100 embodies a significant stride forward […]
Triliptin 100 mg (Trilagliptin) Tablets
Introduction: In the dynamic landscape of cancer care, where each breakthrough shapes the future, Drug International Ltd. introduces Triliptin 100 mg. This innovative medication, featuring Trilagliptin, places a spotlight on metabolic well-being, often overlooked in cancer treatment. Supported by Onco Solution, a global leader in medicine supply and information dissemination, Triliptin 100 mg emerges as […]
Pazonib 200 MG (Pazopanib) Tablets
Introduction: In the vast expanse of oncology, where hope intertwines with healing, Drug International Ltd. unveils Pazonib 200 , a beacon of therapeutic optimism featuring Pazopanib. Collaborating with Onco Solution, a global leader in oncology medicine supply and information provision, Pazonib 200 emerges as a stalwart in the fight against cancer. This narrative aims to […]
Cerinib 150 MG (Ceritinib) Capsules
Introduction of Cerinib 150 MG In the expansive landscape of oncology, where precision and innovation intertwine, Drug International Ltd. unveils Cerinib 150 , a groundbreaking therapeutic featuring the potent Ceritinib. In collaboration with Onco Solution, a global leader in oncology medicine supply and information dissemination, Cerinib 150 emerges as a beacon of hope in the […]
Latinib 250 MG (Lapatinib) Tablets
Introduction: In the dynamic field of oncology, where breakthroughs redefine treatment paradigms, Drug International Ltd. introduces Latinib 250 mg, featuring the potent Lapatinib. Positioned as a cornerstone in the therapeutic arsenal against specific cancer types, Latinib 250 represents a beacon of hope for patients worldwide. Through a strategic partnership with Onco Solution, a global leader […]
Sutinib 50 MG (Sunitinib) Capsules
Introduction to Sutinib 50 MG (Sunitinib) Capsules: Sutinib 50 , expertly developed by Beacon Pharmaceuticals Ltd. and distributed by Onco Solution, is a potent cancer treatment used to manage various malignancies. Sunitinib, the active component, is a multi-targeted receptor tyrosine kinase (RTK) inhibitor that disrupts cancer cell growth and proliferation. Description: Sutinib 50 MG (Sunitinib) […]
